Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Nov;60(5):1190-201.
doi: 10.1016/S0006-3495(91)82154-3.

pH-dependent structural transitions of Alzheimer amyloid peptides

Affiliations

pH-dependent structural transitions of Alzheimer amyloid peptides

P E Fraser et al. Biophys J. 1991 Nov.

Abstract

To understand the molecular interactions leading to the assembly of beta/44 protein into the hallmark fibrils of Alzheimer's disease (AD), we have examined the ability of synthetic peptides that correspond to the beta/A4 extracellular sequence to form fibrils over the range of pH 3-10. Peptides included the sequences 1-28, 19-28, 17-28, 15-28, 13-28, 11-28, and 9-28 of beta/A4. The model fibrils were compared with isolated amyloid with respect to morphology, conformation, tinctorial properties, and stability under denaturing conditions. Electron microscopy, Fourier-transform infrared (FT-IR) spectroscopy, and x-ray diffraction revealed that the ionization states of the amino acid sidechains appeared to be a crucial feature in fibril formation. This was reflected by the ability of several peptides to undergo fibril assembly and disassembly as a function of pH. Comparisons between different beta/A4 sequences demonstrated that the fibrillar structure representative of AD amyloid was dependent upon electrostatic interactions, likely involving His-13 and Asp-23, and hydrophobic interactions between uncharged sidechains contained within residues 17-21. The results also indicated an exclusively beta-sheet conformation for the synthetic (and possibly AD fibrils) in contrast to certain other (e.g., systemic) amyloids.

PubMed Disclaimer

References

    1. Nature. 1988 Feb 11;331(6156):528-30 - PubMed
    1. J Mol Biol. 1968 Mar 14;32(2):343-58 - PubMed
    1. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6338-42 - PubMed
    1. Annu Rev Neurosci. 1989;12:463-90 - PubMed
    1. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4506-10 - PubMed

Publication types

LinkOut - more resources